Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord while Preserving Peripheral Regulatory Mechanisms()

Plasma cells and the autoreactive Abs they produce are suspected to contribute to the pathogenesis of multiple sclerosis, but recent attempts to target these components of humoral immunity have failed. MEDI551, an anti-CD19 Ab that depletes mature B cells including plasma cells may offer a compellin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol
Main Authors: Chen, Ding, Blazek, Monica, Ireland, Sara, Ortega, Sterling, Kong, Xiangmei, Meeuwissen, Anouk, Stowe, Ann, Carter, Laura, Wang, Yue, Herbst, Ronald, Monson, Nancy L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4373313/
https://ncbi.nlm.nih.gov/pubmed/25281717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1401478
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados